GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
25 hedge funds and large institutions have $26.5M invested in GeneDx Holdings Warrant in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
11% less funds holding
Funds holding: 28 → 25 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
64% less capital invested
Capital invested by funds: $73.7M → $26.5M (-$47.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
+$593K |
| 2 |
ACM
Arrow Capital Management
New York
|
+$150K |
| 3 |
GS
Gagnon Securities
New York
|
+$116K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$66.1K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$42.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
-$37.2M |
| 2 |
AC
Athanor Capital
New York
|
-$1.34M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$1.03M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$525K |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
-$439K |
WGSWW Hedge Fund Activity: Q2 2021 in Review
25 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2021, worth a combined $26.5M — down 64% from $73.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of WGSWW and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Ionic Capital Management, adding an estimated $593K. The largest seller was SB Management, exiting entirely with an estimated $37.2M sold.
- 25 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2021, down from 28 in Q1 2021.
- Funds reported $26.5M of GeneDx Holdings Warrant stock for Q2 2021, down 64% quarter-over-quarter.
- 4 funds opened new GeneDx Holdings Warrant positions in Q2 2021 and 7 closed out, a net change of -3 holders.
- The largest GeneDx Holdings Warrant buyer in Q2 2021 was Ionic Capital Management, an estimated $593K added.
- The largest GeneDx Holdings Warrant seller in Q2 2021 was SB Management, an estimated $37.2M sold.
Based on aggregated 13F filings for Q2 2021.